Advancing Oligonucleotide & Peptide Therapeutics from Clinical R&D to Manufacturing in Asia
Join the Oligonucleotides & Peptides World Asia Congress 2026, where industry leaders from biopharma and big pharma converge to foster collaboration, breakthrough therapies, and scalable manufacturing in Asia’s rapidly growing oligonucleotide and peptide sector.
Attendees
Companies
Speakers
Networking Hours
Case Studies
About The Event
The Oligonucleotides & Peptides World Asia Congress 2026 is the region’s leading platform dedicated to advancing oligonucleotide and peptide-based therapeutics across the value chain , from early-stage R&D and clinical trials to large-scale manufacturing.
As Asia emerges as a key hub for next-generation therapeutics, this Congress brings together biopharma and big pharma leaders and regulatory experts to exchange insights, explore innovation, and strengthen regional collaboration. Through a carefully curated program featuring case studies from across APAC, the Congress aims to accelerate development pipelines and manufacturing excellence in oligonucleotide and peptide therapies.
Spanning eight focused sessions, the Oligonucleotides & Peptides World Asia Congress 2026 will explore the latest in ASOs, siRNA, and peptide therapeutics; innovative delivery and formulation technologies; and advances in clinical trials and translational research across APAC. The program will also address scalable manufacturing, evolving regulatory frameworks, emerging digital and platform innovations, and best practices in quality and analytical strategies — offering a comprehensive view of Asia’s growing oligonucleotide and peptide ecosystem from R&D to large-scale production.
Join us at Oligonucleotides & Peptides World Asia Congress 2026 to connect with leading experts, gain actionable insights, and be part of the movement shaping Asia’s oligonucleotide and peptide revolution.
Agenda at a Glance
Peptide Therapeutics: Innovation & Market Trends
- Focus: Peptide drug design, stability, and bioavailability challenges.
- Highlights: Emerging modalities, targeted delivery systems, and APAC examples of peptide therapies in development or early trials.
Next-Generation Oligonucleotide Therapeutics
- Focus: Latest research in antisense oligonucleotides (ASOs), siRNA, and mRNA therapies.
- Highlights: Novel delivery strategies, clinical trial insights, and APAC case studies showcasing regional R&D success.
Clinical Trials & Translational Research
- Focus: Designing and executing clinical trials for oligonucleotide and peptide therapies.
- Highlights: Trial design, biomarkers, patient recruitment strategies, and APAC-specific case studies of successful translational research.
Manufacturing & Scale-Up
- Focus: Industrial-scale production challenges and solutions.
- Highlights: cGMP compliance, process optimization, quality control, cost-efficiency strategies, and APAC-based manufacturing success stories.
Regulatory & Safety Landscape in Asia
- Focus: Regulatory requirements and approvals for oligonucleotide and peptide therapeutics in Asia.
- Highlights: Navigating regional guidelines, safety assessments, clinical trial regulations, and real-world APAC case studies of regulatory submissions.
Quality, Analytical & Characterization Strategies
- Focus: Ensuring the quality, purity, and consistency of oligonucleotide and peptide therapeutics.
- Highlights: Analytical method development, characterization techniques, stability testing, and APAC case studies demonstrating best practices in quality control.
Delivery Technologies & Formulation Strategies
- Focus: Overcoming delivery hurdles for oligonucleotides and peptides.
- Highlights: Nanoparticles, lipid-based carriers, conjugates, oral formulations, and regional case studies demonstrating innovative delivery solutions in APAC.
Emerging Technologies & Platform Innovations
- Focus: AI-driven design, high-throughput screening, and novel synthesis platforms.
- Highlights: Digital tools for faster R&D, improving therapeutic efficacy, and APAC examples of platform innovations accelerating development locally.
